Complementary effect of Roe's congenital heart disease treatment compared to Wade's

Published Date: 16 Feb 2023

As more states repeal or restrict abortion laws, the number of patients, the number of workers needed, and the cost of heart disease will increase. How should hospitals and policy makers prepare?

Read Full News

Latest News

ENCIRCLE trial transforms treatment of mitral regurgitation

David Daniels, M.D., an interventional cardiologist with Sutter West Bay Medical Group and structural heart section chief of Sutter's Advanced Heart & Vascular Service Line, presented results of the international ENCIRCLE ...

Algorithm can predict and lengthen pacemaker battery life

Scientists have found a way to pick the best pacemaker for each patient, potentially making them last years longer.

RNA-based biomarkers could make it easier to detect heart failure in women

Diagnosing heart failure in women can be particularly challenging. New research on biomarkers may lead to more accurate diagnoses for heart failure, in both women and men.

Computational model helps personalize neurostimulation therapy for atrial fibrillation

Atrial fibrillation (AFib) is a cardiac disorder in which the chambers of the heart beat rapidly and irregularly. It's the most common type of arrhythmia and the leading cardiac cause of stroke.

GLIS model as a predictor of outcomes in older adults with heart failure

With populations aging rapidly worldwide, heart failure has become one of the most pressing medical and social challenges. Older patients face not only a high mortality risk but also losses in muscle strength, mobility, and ...

Addressing underdiagnoses of pregnancy-related heart failure

Peripartum cardiomyopathy (PPCM) is a rare but life-threatening condition that can affect women with previously healthy hearts a few weeks before or after giving birth. It causes a severe reduction in the pumping capacity ...

Todays Updates

Molecular profiling of renal medullary carcinoma identifies TROP2 as a promising therapeutic target

Researchers at The University of Texas MD Anderson Cancer Center, in collaboration with BostonGene, conducted the largest and most comprehensive molecular analysis of renal medullary carcinoma (RMC), a rare and aggressive ...

FDA approves Blenrep for relapsed or refractory multiple myeloma

The U.S. Food and Drug Administration approved Blenrep (belantamab mafodotin-blmf) in combination with bortezomib and dexamethasone for the treatment of adult patients with relapsed or refractory multiple myeloma.

Todays Updates

Molecular profiling of renal medullary carcinoma identifies TROP2 as a promising therapeutic target

Researchers at The University of Texas MD Anderson Cancer Center, in collaboration with BostonGene, conducted the largest and most comprehensive molecular analysis of renal medullary carcinoma (RMC), a rare and aggressive ...

FDA approves Blenrep for relapsed or refractory multiple myeloma

The U.S. Food and Drug Administration approved Blenrep (belantamab mafodotin-blmf) in combination with bortezomib and dexamethasone for the treatment of adult patients with relapsed or refractory multiple myeloma.

Latest News

David Daniels, M.D., an interventional cardiologist with Sutter West Bay Medical Group and structural heart section chief of Sutter's Advanced Heart & Vascular Service Line, presented results of the international ENCIRCLE ...

Scientists have found a way to pick the best pacemaker for each patient, potentially making them last years longer.

Diagnosing heart failure in women can be particularly challenging. New research on biomarkers may lead to more accurate diagnoses for heart failure, in both women and men.

Atrial fibrillation (AFib) is a cardiac disorder in which the chambers of the heart beat rapidly and irregularly. It's the most common type of arrhythmia and the leading cardiac cause of stroke.

With populations aging rapidly worldwide, heart failure has become one of the most pressing medical and social challenges. Older patients face not only a high mortality risk but also losses in muscle strength, mobility, and ...

Peripartum cardiomyopathy (PPCM) is a rare but life-threatening condition that can affect women with previously healthy hearts a few weeks before or after giving birth. It causes a severe reduction in the pumping capacity ...

News All Time

Cutting balloon treatment found to be 'safe and effective' for patients with calcified coronary artery disease

Results from the first randomized controlled trial to directly compare the safety and efficacy of cutting balloon (CB) angioplasty to intravascular lithotripsy (IVL) prior to drug‐eluting stent (DES) implantation for the ...

PCI with a sirolimus-eluting balloon and provisional stenting shows promise for treatment of de novo coronary lesion

New study results from a large international all-comer population of percutaneous coronary intervention (PCI) candidates found that utilizing a strategy of sirolimus-eluting balloons with bailout stenting only if necessary ...

Health data in England show changing patterns of heart diseases before, during and after the pandemic

A comprehensive study of electronic health records for 57 million people living in England has revealed the evolving burden of cardiovascular diseases before, during and after the COVID-19 pandemic.

One long walk a day may cut risk of death and cardiovascular disease better than multiple short walks

A prospective population-based cohort study of suboptimally active adults (

Some cancer patients get heart damage during chemotherapy and some don't: Here's why

Sometimes the unintended consequences of a treatment can seem worse than the disease. That's certainly the case for patients who develop chemotherapy-induced cardiotoxicity—a severe side-effect that can lead to heart failure ...

Drug-eluting balloon may be as safe, effective as conventional stents for repeat percutaneous coronary interventions

A new drug-eluting balloon can perform just as well as the standard treatment for patients with coronary in-stent restenosis (ISR) undergoing repeated percutaneous coronary intervention (PCI). These breakthrough findings ...

Metabolomics, proteomics improve prediction of elevated blood pressure in teens

For adolescents, metabolomics and proteomics with known risk factors improve prediction of elevated blood pressure (EBP) after bariatric surgery, according to a study published online Oct. 20 in Hypertension.

Why energy transport in the heart fails in hypertrophic cardiomyopathy

Hypertrophic cardiomyopathy (HCM) is the most common hereditary heart disease. It causes the left ventricle to thicken, the heart muscle to contract too strongly and work too hard. This additional strain puts pressure on ...

New drug tested in mice could fill treatment void for most severe heart attack patients

A new drug being trialed in heart attack patients could reprogram the immune system to prevent inflammation and heart damage following severe heart attacks, and promote repair. This could be a game-changer in treating the ...

What will stroke care look like in 2050?

For more than 40 years as a researcher and clinician, Joseph Broderick has actively contributed to improvements in stroke care, occupying a front row seat to seismic innovations: the clinical trials that proved tPA as the ...

Researchers uncover metabolic mysteries behind heart failure

In the U.S. alone, more than 6.7 million people have heart failure, a number that is projected to increase to more than 8.5 million by 2030. Heart failure is a progressive condition in which the heart struggles to pump enough ...

Nighttime light exposure linked to higher heart attack and stroke rates

A new study led by Flinders University has found that being exposed to bright light at night can significantly increase the chances of developing serious heart problems, including heart attacks, strokes and heart failure.

Gum disease may raise stroke risk, even damage the brain

If you need another reason to brush and floss, here it is: Research suggests keeping your mouth healthy might also protect your brain and heart.

Why your late teens and early 20s are crucial times for lifelong heart health

Emerging adulthood—the life stage that unfolds around ages 18–25—is full of major transitions, such as starting college or learning a trade, making new friends and romantic connections, and generally becoming more independent.

Nerandomilast slows decline in forced vital capacity in idiopathic pulmonary fibrosis

For U.S. patients with idiopathic pulmonary fibrosis (IPF), nerandomilast slows the decline in forced vital capacity (FVC), according to a study presented at CHEST 2025, the annual meeting of the American College of Chest ...

Drug prevents congenital heart block recurrence in a high-risk pregnancy

Congenital heart block, sometimes referred to as cardiac neonatal lupus, is a rare but potentially life-threatening condition that affects babies born to mothers with specific autoantibodies—called anti-SSA/Ro antibodies—which ...

Recommended News For You

A specific drug combination is being tested in a clinical trial for the deadly brain cancer glioblastoma.

Study finds common genetic target may halt breast cancer cell growth

Two-part prodrug system activates immune attack only in tumor's unique environment

AI-based liquid biopsy shows promise for detecting brain cancer

Drug-chemo combo increases cancer treatment efficacy

Quality of Life Similar With Proton Beam Therapy vs IMRT for Prostate Cancer

To refute accusations that it failed to issue a cancer warning, Roundup's maker is asking lawmakers for assistance.

Recommended Articles For You

Oncology Drug Trends 2025: FDA Approvals, Immuno-Oncology, and Clinical Trial Insights 

Unlocking the Unknown: A Comprehensive Guide to Stage 4 Vulvar Cancer 

Elevating Hematology Oncology: Modern Approaches for Smarter Diagnosis and Treatment 

Cracking the Code of Subdural Hematomas: Modern Strategies for Optimal Care 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Adjuvant ICIs: A Winner and a Loser in Clear Cell Renal Cell Carcinoma?

2.

Study opens up possibility of bespoke prostate cancer treatment

3.

Having dense breasts is linked to cancer, but advice about breast density can depend on where you live

4.

What does it mean for Biden's prostate cancer to be 'aggressive'? A urologic surgeon explains

5.

Rural residents continue to have higher odds of skin cancer, study finds

1.

Asymptomatic Thrombocytopenia: Unraveling the Enigma of Low Platelet Counts Without Symptoms

2.

Hope for a Cure: Exploring New Treatments for Sickle Cell Anemia

3.

Personalized Cancer Vaccines: The Next Frontier in Precision Oncology

4.

Optimizing the Diagnosis and Treatment of Hematological Diseases Through Artificial Intelligence

5.

Unlocking the Potential of Hemin: A Novel Approach to Health and Wellbeing

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part IV

2.

An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion- Part II

3.

Navigating the Complexities of Ph Negative ALL - Part X

4.

Targeting Oncologic Drivers with Dacomitinib: Further Discussion on Lung Cancer Treatment

5.

INO-VATE: The Long-Term Overall Survival Analysis in Iontuzumab-Treated Patients

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot